Clinical Trial Update: Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluated intravitreal bevacizumab for proliferative diabetic retinopathy and related retinal complications. The study results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Tractional Retinal Detachment
• Proliferative Diabetic Retinopathy
• Vitreous Hemorrhage

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Nihon University | Conditions: Proliferative Diabetic Retinopathy, Diabetic Traction Retinal Detachment | Phase 4 | Status: COMPLETED | Results posted: 2014-07-14